DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China
· Delayed Price · Currency is CNY 19.35
+0.60 (3.20%)
Apr 29, 2026, 3:00 PM CST
SHA:603233 Revenue
DaShenLin Pharmaceutical Group had revenue of 6.97B CNY in the quarter ending March 31, 2026, with 0.25% growth. This brings the company's revenue in the last twelve months to 27.52B, up 3.07% year-over-year. In the year 2025, DaShenLin Pharmaceutical Group had annual revenue of 27.50B with 3.80% growth.
Revenue (ttm)
27.52B
Revenue Growth
+3.07%
P/S Ratio
0.78
Revenue / Employee
632.17K
Employees
43,532
Market Cap
21.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 27.50B | 1.01B | 3.80% |
| Dec 31, 2024 | 26.50B | 1.97B | 8.01% |
| Dec 31, 2023 | 24.53B | 3.28B | 15.45% |
| Dec 31, 2022 | 21.25B | 4.49B | 26.78% |
| Dec 31, 2021 | 16.76B | 2.18B | 14.92% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Yifeng Pharmacy Chain | 24.51B |
| LBX Pharmacy Chain Joint Stock Company | 22.28B |
| Anhui Huaren Health Pharmaceutical | 5.64B |
| Yixintang Pharmaceutical Group | 17.41B |
| ShuYu Civilian Pharmacy Corp. | 9.94B |
| Luyan Pharma | 21.42B |
| Cachet Pharmaceutical | 19.53B |
| Jianzhijia Pharmaceutical Chain Group | 9.10B |